Vijaya R Bhatt, MBBS, MS (@vijayarbhatt1) 's Twitter Profile
Vijaya R Bhatt, MBBS, MS

@vijayarbhatt1

Professor, Section Leader, Malignant Hematology, @UNMC @NebraskaMed. Proud Father of n=2. Interests: AML in older adults #AML #leuksm #BMTsm #gerionc #geriheme

ID: 1358902655322644482

linkhttps://www.ncbi.nlm.nih.gov/myncbi/1p9rs6cSgotkR/bibliography/public/ calendar_today08-02-2021 22:17:40

663 Tweet

894 Followers

576 Following

University of Nebraska System (@u_nebraska) 's Twitter Profile Photo

Researchers across the NU System are changing the way today’s problems are solved. And they are changing lives for the better—here in Nebraska and across the nation and world. Join us in showcasing and celebrating groundbreaking research today as we kick off #ILoveNU Week.

Researchers across the NU System are changing the way today’s problems are solved. And they are changing lives for the better—here in Nebraska and across the nation and world. Join us in showcasing and celebrating groundbreaking research today as we kick off #ILoveNU Week.
UNMC Research (@unmc_research) 's Twitter Profile Photo

In the latest “Heart to Heart” podcast, Dr. Joann Sweasy recalled losing a young cousin to leukemia. “At that point, I knew that I would have a career in research,” Dr. Sweasy said. “I knew that in some way, research would help to cure cancer.” #ILoveNU unmc.edu/newsroom/2025/…

Vijaya R Bhatt, MBBS, MS (@vijayarbhatt1) 's Twitter Profile Photo

Our manuscript with Dr. Dhakal that highlights a road map to enhance academic community collaboration in #AML, such an important topic everywhere, more so in rural states UNMC Research Fred & Pamela Buffett Cancer Center

Kimryn Rathmell (@kimrynrathmell) 's Twitter Profile Photo

I’m honored to serve as the next CEO of the @osuccc_james & look forward to joining my new Buckeye colleagues at @osuwexmed & @ohiostate to take bold steps to advance the future of oncology across Ohio & nationally. Check out my LinkedIn to learn more. go.osu.edu/C4w3

University of Nebraska System (@u_nebraska) 's Twitter Profile Photo

From the jobs we create to the workforce we educate and the research we produce, the University of Nebraska is helping move our state forward in meaningful ways. Learn more about NU’s economic impact on Nebraska: nebraska.edu/economic-impact

From the jobs we create to the workforce we educate and the research we produce, the University of Nebraska is helping move our state forward in meaningful ways. Learn more about NU’s economic impact on Nebraska: nebraska.edu/economic-impact
Fred & Pamela Buffett Cancer Center (@buffettcancer) 's Twitter Profile Photo

Exciting news! Paul Trippier, PhD has received an R21 grant for his work on flupirtine analogues—developing safer medications that effectively manage chemotherapy-induced neuropathic pain without associated liver toxicity. Congrats! #UNMC #CancerResearch

Exciting news! Paul Trippier, PhD has received an R21 grant for his work on flupirtine analogues—developing safer medications that effectively manage chemotherapy-induced neuropathic pain without associated liver toxicity. Congrats! #UNMC #CancerResearch
Alain Mina (@dralainmina) 's Twitter Profile Photo

Bidding farewell to a giant, a mentor, and above all, a friend. Congratulations Steven Pavletic M.D., Ph.D. on an incredible career; can’t wait to see what your next chapter holds. NIH National Cancer Institute

Bidding farewell to a giant, a mentor, and above all, a friend. Congratulations <a href="/StevenPavletic/">Steven Pavletic M.D., Ph.D.</a> on an incredible career; can’t wait to see what your next chapter holds. <a href="/NIH/">NIH</a> <a href="/theNCI/">National Cancer Institute</a>
Fred & Pamela Buffett Cancer Center (@buffettcancer) 's Twitter Profile Photo

Last Friday, we hosted a "Bench to Bedside" Investigator-Initiated Trials workshop to spark collaboration between basic, translational & clinical scientists—accelerating innovation & ensuring discoveries don't get stuck in the lab. #TeamScience #CancerResearch

Last Friday, we hosted a "Bench to Bedside" Investigator-Initiated Trials workshop to spark collaboration between basic, translational &amp; clinical scientists—accelerating innovation &amp; ensuring discoveries don't get stuck in the lab. #TeamScience #CancerResearch
Journal of Clinical Investigation (@jclinicalinvest) 's Twitter Profile Photo

ICYMI: How does lung adenocarcinoma evade the immune system? This issue’s cover features work by Imay Lakshmanan & team showing aberrant sialylation promotes immune evasion & tumor angiogenesis in non–small cell lung cancer: jci.org/articles/view/… Imay Lakshmanan

ICYMI: How does lung adenocarcinoma evade the immune system?

This issue’s cover features work by Imay Lakshmanan &amp; team showing aberrant sialylation promotes immune evasion &amp; tumor angiogenesis in non–small cell lung cancer: jci.org/articles/view/…

<a href="/ImayavarambanL/">Imay Lakshmanan</a>
Alliance for Clinical Trials in Oncology (@alliance_org) 's Twitter Profile Photo

Clinical trials are more than a process—they're a promise. A promise to patients that we'll continue to push boundaries, ask the hard questions, & never stop striving for better answers. Today, on #InternationalClinicalTrialsDay, we celebrate that commitment! #CTD25 #NCTN #NCORP

Clinical trials are more than a process—they're a promise. A promise to patients that we'll continue to push boundaries, ask the hard questions, &amp; never stop striving for better answers. Today, on #InternationalClinicalTrialsDay, we celebrate that commitment! #CTD25 #NCTN #NCORP
Marlise R. Luskin MD, MSCE (@luskinmarlise) 's Twitter Profile Photo

I'll be at #ASCO25 to present A phase I study of asciminib in combination with dasatinib, prednisone, and blinatumomab for Ph-positive acute leukemia in adults (6509). Join me Friday 1PM Room E450a. bit.ly/3Hc6pXn

Lymphoma Hub (@lymphomahub) 's Twitter Profile Photo

CONGRESS | #ASCO25 | PRESENTATION Julie Vose University of Nebraska Medical Center Nebraska Medicine shares insights on incorporating epcoritamab into clinical practice for the treatment of patients with R/R FL. They highlight results from the pivotal FL cohort of the EPCORE NHL-1 trial (N = 128) and discuss key

CONGRESS | #ASCO25 | PRESENTATION
<a href="/DrJulieVose/">Julie Vose</a> <a href="/unmc/">University of Nebraska Medical Center</a> <a href="/NebraskaMed/">Nebraska Medicine</a> shares insights on incorporating epcoritamab into clinical practice for the treatment of patients with R/R FL.
They highlight results from the pivotal FL cohort of the EPCORE NHL-1 trial (N = 128) and discuss key
Julie Vose (@drjulievose) 's Twitter Profile Photo

Interesting #ASCO25 session on incorporating new agents into standard practice. Fun to compare new agents used to treat lung, breast cancer, CNS, and lymphoma: how to use them in the community.

Jeffrey P. Gold, M.D. (@uofne_president) 's Twitter Profile Photo

Thankful to have joined university leaders, elected officials & partners to celebrate the grand opening of the Catalyst building in University of Nebraska Medical Center's EDGE District this week. I look forward to the many creative & transformative collaborations to come. unmc.edu/newsroom/2025/…

Fred & Pamela Buffett Cancer Center (@buffettcancer) 's Twitter Profile Photo

Recent study in Journal of Cancer Survivorship finds cognitive impairment nearly doubled in older adults 3 months after stem cell transplant. MoCA screening can help identify at-risk patients early! Great work Thuy Koll, MD, Vijaya R Bhatt, MBBS, MS, Daisy Dai, PhD & Tanya Wildes, MD! link.springer.com/article/10.100…